Special issue: Cyclodextrin‑Based Advanced Formulations
The aim of this Special Issue in Pharmaceutics, “Cyclodextrin-Based Advanced Formulations”, is to provide a comprehensive and interdisciplinary platform for
Special issue: Cyclodextrin‑Based Advanced Formulations
The aim of this Special Issue in Pharmaceutics, “Cyclodextrin-Based Advanced Formulations”, is to provide a comprehensive and interdisciplinary platform for
Grafted β-Cyclodextrin Copolymers as Superplasticizing Admixtures for Cement Mortar
Synthetic-based plasticizers are often used in the masonry industry to improve the rheological and mechanical properties of mortar, but these
Fast-Dissolving Cyclodextrin Nanofibers for Pain Relief
A fast-dissolving nanofibrous film based on cyclodextrin (hydroxypropyl-β-cyclodextrin) inclusion complexes (ICs) incorporating a triple drug combination of acetylsalicylic acid (Aspirin),
Concluding 22nd International Cyclodextrin Symposium (ICS-22)
From October 23 to 25, 2026, cyclodextrin scientists from 26 Indian states and 15 countries gathered at the ISF College
Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
Epichlorohydrin-crosslinked β-cyclodextrin polymers (pCDs) are versatile drug carriers that solubilize poorly water-soluble molecules and exhibit intrinsic biological activity. However, the
Book chapter: Functionalized cyclodextrins in drug delivery
The book : Engineered Biomaterials for Drug Delivery (Edited by: Amit Kumar Nayak, Md Saquib Hasnain and Tejraj M. Aminabhavi)
β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
Researchers from Brazil 🇧🇷 tested βCD-complexed 1,8-cineole (Eucalyptol) in mice with Parkinson-like symptoms. Daily treatment reduced tremors and other movement
Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
While β-cyclodextrins are commonly associated with cholesterol extraction, it remains unclear whether this mechanism alone explains their biological activity. Here,
New Hungarian Medicine on the Horizon?
Motorpharma Ltd., a Hungarian biotechnology company, has developed a number of promising experimental drugs targeting the motor proteins (e.g. myosins)
Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
Rafael Holdings, Inc. (NYSE: RFL) announced on Oct. 29 that its subsidiary, Cyclo Therapeutics, LLC, has submitted a New Drug